117
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Eye Lesions in Patients After One Year of Kidney Transplantation

ORCID Icon, ORCID Icon, , &
Pages 2861-2869 | Received 26 Jun 2023, Accepted 18 Sep 2023, Published online: 29 Sep 2023

References

  • Thomas AG, Ruck JM, Chu NM, et al. Kidney transplant outcomes in recipients with visual, hearing, physical and walking impairments: a prospective cohort study. Nephrol Dial Transplant. 2020;35(7):1262–1270. doi:10.1093/ndt/gfz164
  • Berindán K, Nemes B, Szabó RP, Módis L. Ophthalmic findings in patients after renal transplantation. Transplant Proc. 2017;49(7):1526–1529. doi:10.1016/j.transproceed.2017.06.016
  • Ginu PM, Sati A, Murari T, Kaushik J, Mishra SK, Sharma VK. Ocular manifestations in renal allograft recipients: an Indian perspective. Indian J Ophthalmol. 2021;69(4):900–905. doi:10.4103/ijo.IJO_1120_20
  • Kianersi F, Taheri S, Fesharaki S, et al. Ocular manifestations in hemodialysis patients: importance of ophthalmic examination in prevention of ocular sequels. Int J Prev Med. 2019;10:20. doi:10.4103/ijpvm.IJPVM_464_18
  • Sandhu JS, Kansal S, Bajwa GS, Sandhu J. Ocular changes in renal allograft recipients and patients of chronic kidney disease. Saudi J Kidney Dis Transpl. 2014;25(6):1285–1289. doi:10.4103/1319-2442.144269
  • Porter R, Crombie AL. Corneal and conjunctival calcification in chronic renal failure. Br J Ophthalmol. 1973;57(5):339–343. doi:10.1136/bjo.57.5.339
  • Buratto L, Apple DJ. Phacoemulsification: Principles and Techniques. Slack Incorporated; 2003.
  • Wong TY. Fred Hollows lecture: hypertensive retinopathy - a journey from fundoscopy to digital imaging. Clin Exp Ophthalmol. 2006;34(5):397–400. doi:10.1111/j.1442-9071.2006.01233.x
  • Ab Gani NH, Ibrahim M, Wan Hitam WH, Masnon NA, Hassan A. Bilateral optic atrophy in a young patient with chronic anaemia secondary to end-stage renal disease. Cureus. 2021;13(3):e13969. doi:10.7759/cureus.13969
  • Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017;15(3):539–574. doi:10.1016/j.jtos.2017.05.001
  • Mondal RN, Matin MA, Rani M, et al. Journal of hypertension: open access; 2017.
  • Cobo G, Hecking M, Port FK, et al. Sex and gender differences in chronic kidney disease: progression to end-stage renal disease and haemodialysis. Clin Sci. 2016;130(14):1147–1163. doi:10.1042/cs20160047
  • Popovtzer MM, Pinnggera W, Katz FH, et al. Variations in arterial blood pressure after kidney transplantation. Relation to renal function, plasma renin activity, and the dose of prednisone. Circulation. 1973;47(6):1297–1305. doi:10.1161/01.cir.47.6.1297
  • Ohno S, Ishii A, Yanagita M, Yokoi H. Calcium channel blocker in patients with chronic kidney disease. Clin Exp Nephrol. 2022;26(3):207–215. doi:10.1007/s10157-021-02153-1
  • Kraus MA, Kalra PA, Hunter J, Menoyo J, Stankus N. The prevalence of vascular calcification in patients with end-stage renal disease on hemodialysis: a cross-sectional observational study. Ther Adv Chronic Dis. 2015;6(3):84–96. doi:10.1177/2040622315578654
  • Caldeira JA, Sabbaga E, Ianhez LE. Conjunctival and corneal changes in renal failure. Influence of renal transplantation. Br J Ophthalmol. 1970;54(6):399–404. doi:10.1136/bjo.54.6.399
  • Albert K, Sennesael J, Haentjens P. Incidence and risk factors for posttransplant subcapsular cataract: a long-term retrospective cohort study. Transplant Proc. 2011;43(9):3465–3469. doi:10.1016/j.transproceed.2011.10.007
  • Kolonko P-MJ, Pinocy-Mańdok J, Kocierz M, et al. ”Anemia and erythrocytosis after kidney transplantation: a 5-year graft function and survival analysis”. Transplant Proc. 2009;41(8):3046–3051. doi:10.1016/j.transproceed.2009.07.090
  • Wilkinson-Berka JL, Agrotis A, Deliyanti D. The retinal renin-angiotensin system: roles of angiotensin II and aldosterone. Peptides. 2012;36(1):142–150. doi:10.1016/j.peptides.2012.04.008
  • Chillo P, Ismail A, Sanyiwa A, Ruggajo P, Kamuhabwa A. Hypertensive retinopathy and associated factors among nondiabetic chronic kidney disease patients seen at a tertiary hospital in Tanzania: a cross-sectional study. Int J Nephrol Renovasc Dis. 2019;12:79. doi:10.2147/IJNRD.S196841
  • van Dijk EHC, Soonawala D, Rooth V, et al. Spectrum of retinal abnormalities in renal transplant patients using chronic low-dose steroids. Graefes Arch Clin Exp Ophthalmol. 2017;255(12):2443–2449. doi:10.1007/s00417-017-3823-6
  • Jahadi-hosseini HR, Rahmani B, Karbassi A, Mehrian M, Medghalchi AR. Ocular complications in renal allograft recipients. Transplant Proc. 2003;35(1):309–310. doi:10.1016/s0041-1345(02)03986-6
  • Jobling AI, Augusteyn RC. What causes steroid cataracts? A review of steroid-induced posterior subcapsular cataracts. Clin Exp Optom. 2002;85(2):61–75. doi:10.1111/j.1444-0938.2002.tb03011.x
  • Ishida H, Mitamura T, Takahashi Y, et al. Cataract development induced by repeated oral dosing with FK506 (tacrolimus) in adult rats. Toxicology. 1997;123(3):167–175. doi:10.1016/s0300-483x(97)00102-9
  • Shao X, He Z, Tang L, Gao L. Tacrolimus-associated ischemic optic neuropathy and posterior reversible encephalopathy syndrome after small bowel transplantation. Transplantation. 2012;94(9):e58–60. doi:10.1097/TP.0b013e31826dde21
  • Moon JJ, Kim YW, Oh BL, et al. Nationwide Glaucoma incidence in end stage renal disease patients and kidney transplant recipients. Sci Rep. 2021;11(1):7418. doi:10.1038/s41598-021-86846-3